Literature DB >> 3980087

Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.

M Phillips, T K Eisenstein, J Meissler.   

Abstract

We show that formaldehyde fixation of Salmonella typhimurium lipopolysaccharide (LPS) to ribosomes purified from Brucella abortus induced a primary immunoglobulin M (IgM) response to LPS in C3H/HeJ mice and upon revaccination resulted in elevated titers of IgM and induction of IgG antibody to the O antigens of LPS, as measured by an enzyme-linked immunosorbent assay. A similar LPS-Aspergillus fumigatus ribosomal complex yielded IgM and IgG antibody to LPS only after secondary stimulation. These results demonstrate that the hyporesponsiveness of C3H/HeJ mice with respect to antibody formation to LPS can be overcome by complexing this molecule to ribosomal particles and provide a theoretical mechanism for the action of some "ribosomal" vaccines. The results are compatible with the hypothesis that LPS in complex with the ribosomes is converted to a T-dependent form of the antigen to which the C3H/HeJ mice can respond.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980087      PMCID: PMC261942          DOI: 10.1128/iai.48.1.244-247.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

Review 2.  Reactions of nucleic acids and nucleoproteins with formaldehyde.

Authors:  M Y Feldman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1973

3.  On the mode of reaction of formaldehyde with ribosomes.

Authors:  R Amons; W Möller
Journal:  Biochim Biophys Acta       Date:  1972-06-22

4.  Immunogenicity of toxic and detoxified endotoxin preparations.

Authors:  A Nowotny
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

5.  19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro.

Authors:  G Möller
Journal:  Nature       Date:  1965-09-11       Impact factor: 49.962

6.  Use of formaldehyde fixation for studies of ribonucleoprotein particles by caesium chloride density-gradient centrifugation.

Authors:  A S Spirin; N V Belitsina; M I Lerman
Journal:  J Mol Biol       Date:  1965-12       Impact factor: 5.469

7.  Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities.

Authors:  B J Skidmore; J M Chiller; D C Morrison; W O Weigle
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

8.  Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide.

Authors:  B Andersson; H Blomgren
Journal:  Cell Immunol       Date:  1971-10       Impact factor: 4.868

9.  Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

10.  Humoral and cellular aspects of the immune response to the somatic antigen of Salmonella enteritidis.

Authors:  M Landy; R P Sanderson; A L Jackson
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  2 in total

1.  Physical and morphological characteristics of eucaryotic ribosomes and lipopolysaccharide complexes.

Authors:  M Phillips; K A Brogden
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

2.  Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.

Authors:  V J Levenson; C P Mallett; T L Hale
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.